エーザイ（4523）　TOPLINE RESULTS OF PHASE II CLINICAL STUDY OF ELENBECESTAT IN MCI AND MILD TO MODERATE ALZHEIMER’S DISEASE AT 18-MONTHS 2018/06/05
/-
読み込み中…